Pharmaceutical

GSK obtains approval in Japan for shingles vaccine

The Japanese MHLW has granted approval for a renewed indication of GSK's shingles (herpes zoster) vaccine, Shingrix.

Jun 27, 2023 - 20:00
GSK obtains approval in Japan for shingles vaccine
The Japanese MHLW has granted approval for a renewed indication of GSK's shingles (herpes zoster) vaccine, Shingrix.
Read the original article

Tags:

Previous Article

Inflation reduction act boosts biologic drug venture financing over small molecules

Next Article

Tonix to acquire Upsher-Smith’s migraine products

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Morgan Health wants you to know it’s still here

STAT+: Morgan Health wants you to know it’s still here

Jan 10, 2024

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets

Aurinia slashes workforce by 45% to focus on lupus and ...

Nov 9, 2024

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Oct 18, 2024